Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys monotherapy dosing in chronic hepatitis C patients with end-stage renal disease on hemodialysis
2004-004852-38Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2007
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of interferon alfa in hepatitis C virus infection and end-stage kidney disease (ESKD) (2 arms), sponsored by Roche. Started Feb 2007; status: completed.
02
Drugs
interferon alfa
03
Conditions
hepatitis C virus infectionend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2004-004852-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004852-38.